Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 5, 2024Molecular CancerOpen Access

Chimeric antigen receptor macrophages targeting c-MET(CAR-M-c-MET) inhibit pancreatic cancer progression and improve cytotoxic chemotherapeutic efficacy

View Full Paper
Ask AI
Bookmark
Share

Authors

HZHuaijin ZhengChinese Academy of Medical Sciences & Peking Union Medical CollegeXYXinzhe YangNHNan HuangChinese Academy of Medical Sciences & Peking Union Medical College

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zheng et al. (2024) studied this question.

synapsesocial.com/papers/6a8ea3987564567bef28e3cehttps://doi.org/10.1186/s12943-024-02184-8
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1HGF/c-Met pathway inhibition combined with chemotherapy increases cytotoxic T-cell infiltration and inhibits pancreatic tumour growth and metastasis2023 · 21 citations
  2. 2Insight of pancreatic cancer: recommendations for improving its therapeutic efficacy in the next decade2022 · 19 citations
  3. 3Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors2021 · 219 citations
  4. 4Pancreatic cancer: Advances and challenges2023 · 1,338 citations
  5. 5Chimeric Antigen Receptor Macrophages Target and Resorb Amyloid Plaques in a Mouse Model of Alzheimer’s Disease2023 · 5 citations